The nomogram based on the BOADICEA (Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm) prediction model can be used to predict breast or ovarian cancer risk in individuals with BRCA1 and BRCA2 mutations (15). This evidence concerns the gene BRCA2 and ovarian carcinoma.